The Centers for Medicare & Medicaid Services (CMS) has now released the 2026 MIPS payment adjustments based on the 2024 performance year. The final scores, performance feedback, and payment adjustment determinations are accessible via the Quality Payment Program (QPP) portal.
The 2024 final MIPS score determines whether an individual Eligible Clinician or group receives a positive, negative, or neutral payment adjustment in 2026, and that adjustment will be applied to the Medicare-paid amount for covered professional services in 2026.
Clinicians or groups can view their feedback and final scores by signing in to the QPP website (using their HARP credentials, as applicable).To access final score information anesthesiologists and their groups should sign in to the Quality Payment Program website.
Additional information can be found on the Quality Payment Program Resource page.
Updated Targeted Review Window (Now Through November 14)
If anesthesiologists or their groups believe an error has been made, CMS is allowing an approximately 60-day time frame to request a targeted review. The targeted review period will be open until November 14, 2025.
Although anesthesiologists and their groups may ask for a targeted review for a range of errors, the most common scenarios for a targeted review include if data was submitted under the wrong Tax Identification Number (TIN) or National Provider Identifier (NPI) or if performance categories were not automatically reweighted (e.g., groups qualified for reweighting from the extreme and uncontrollable circumstances policy).
Anesthesiologists and their groups may submit questions to the CMS QPP Service Center by phone at 1-866-288-8292 (TRS: 711) or by email at [email protected].
How to Request a Targeted Review
CMS generally requires documentation to support a targeted review request, which varies by circumstance. If the targeted review request is approved and results in a scoring change, CMS will update your final score and/or associated payment adjustment (if applicable) as soon as technically feasible. Targeted review decisions are final and not eligible for further review.
Please contact the ASA Department of Quality and Regulatory Affairs at [email protected] with any further questions.
Date of last update: October 16, 2025